SEC Form 4 · accession 0001415889-15-001879
MABVAX THERAPEUTICS HOLDINGS, INC. · MBVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth M Cohen
Director
Period of report
May 22, 2015
Accepted (ET)
May 26, 2015 · 1:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001109196
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2015 | P | 3,500 | $2.30 | A | 10,000 | I | By the Cohen-Salsitz Family Trust |
Table II — derivative securities
No Table II lines on this filing.